Skip to content
Clinical Trials – home
Verifiedinfo

Ginefiv S.L.

Spain Calle De Zurbano 51, 28010 Madrid, Spain

  • 2 trials recruiting
  • Infertility female · Controlled ovarian stimulation
  • Adult patients

About Specializations

Ginefiv S.L. in Madrid, Spain specialises in clinical trials of conditions such as Infertility female, Controlled ovarian stimulation, and other specialisations. This site conducts important research.

Main research areas of the site

Ovarian Stimulation Strategies

At Ginefiv S.L. the focus is on improving outcomes for women facing female infertility and those undergoing assisted reproductive technologies. Current studies compare different pituitary suppression methods during double ovarian stimulation to increase the number of euploid embryos for preimplantation genetic testing.

  • Progestin‑primed ovarian stimulation (PPOS) vs GnRH antagonist protocols
  • Double ovarian stimulation (DUOSTIM) with embryo accumulation
  • Use of FE 999302 in combination with follitropin delta
  • Timing variations of FE 999302 during controlled ovarian stimulation

These investigations aim to refine stimulation regimens, enhance embryo quality, and expand treatment options for patients indicated for IVF/ICSI.

Uterine Contractility and Implantation

Research at the clinic also explores how uterine activity influences implantation success in women undergoing IVF. An exploratory trial evaluates the effects of nolasiban on uterine contractility and its potential to improve pregnancy outcomes.

  • Pharmacodynamics of nolasiban dosing regimens
  • Impact of reduced uterine contractility on embryo implantation
  • Safety profile of nolasiban in IVF cycles
  • Potential integration of nolasiban with standard IVF protocols

By targeting uterine contractility, the studies hope to reduce implantation failure and support healthier pregnancies for those with pregnancy complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Calle De Zurbano 5128010 MadridSpain
Recruiting now
2 trials
Conditions studied
2
Partner status
Verified

More sites in MadridSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:SpainSpain
  • Participants:18–64 years
  • Sponsor:ReproNovo ApS
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Ganirelix
  • Sponsor:Ginefiv S.L.
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Follitropin Delta
  • Sponsor:Ferring Pharmaceuticals A/S
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).